Sudarshan Chemical Industries (NSE: SUDARSCHEM) reported a landmark FY2025, with consolidated revenue surging 32% YoY to INR 3,346 crore following the transformative Heubach Group acquisition. Full-year EPS stood at INR 22.5 vs. INR 16 the prior year, while net profit declined sharply to INR 602 crore from INR 3,574 crore due to acquisition-related charges and audit delays. Stock after-hours movement was not formally disclosed; the earnings call was hosted on July 29, 2025, well after the March 31, 2025 year-end.
About Sudarshan Chemical Industries
Sudarshan Chemical Industries Limited (NSE: SUDARSCHEM, BSE: 506655) is India’s largest pigment manufacturer and now a global leader in color solutions, founded in 1951 in Pune, Maharashtra by Dr. R.J. Rathi and L.J. Rathi with a seed capital of INR 340,000. The company manufactures an extensive range of Organic, Inorganic, and Effect Pigments serving the coatings, plastics, inks, and cosmetics industries across more than 120 countries. In FY2024, Sudarshan held approximately 35% market share in India’s pigment industry.
In FY2025, the company executed a landmark acquisition of Germany’s Heubach Group, which had earlier absorbed Clariant’s global pigment business in 2022, creating “One Sudarshan” with 19 manufacturing facilities across 11 countries on 5 continents and a combined turnover of approximately EUR 1 billion. As of March 2026, the stock trades around INR 832, with a market cap of approximately INR 6,549 crore. The current Stock P/E ratio stands at 1,785x on a consolidated basis (highly elevated due to depressed earnings), Book Value is INR 448 per share, Dividend Yield is 0.54%, and ROCE is 6.03%.
Top Financial Highlights
- Consolidated revenue for FY2025 reached INR 3,346 crore, rising 32% from INR 2,539 crore in FY2024
- Legacy Sudarshan revenue grew 11% YoY to INR 2,821 crore on a standalone basis
- The acquired Heubach group contributed INR 525 crore in revenue for March 2025 alone, at an approximately 55.8% gross margin
- Net Profit After Tax came in at INR 602 crore, down sharply from INR 3,574 crore in FY2024, impacted by exceptional acquisition-related charges of INR 104 crore
- Adjusted EBITDA for One Sudarshan reached INR 402 crore, up 27% from INR 316 crore in FY2024
- Gross margin expanded to 47% for One Sudarshan in FY2025, compared to 44.2% the prior year
- EPS on a standalone basis stood at INR 22.5 versus INR 16 in FY2024, while consolidated diluted EPS fell to INR 7.86 from INR 51.63 due to acquisition dilution
- Q4 FY2025 revenue for One Sudarshan reached INR 1,349 crore versus INR 764 crore in Q4 FY2024, reflecting one month of the acquired group
- Q4 FY2025 Adjusted EBITDA for One Sudarshan improved to INR 148 crore from INR 119 crore in Q4 FY2024
- Operating cash flow fell 80.9% to INR 370 million in FY2025 from INR 1,935 million in FY2024, reflecting integration-related working capital pressure
- Net debt at year-end stood at approximately INR 650 crore with a comfortable net debt-to-equity ratio of 0.3x
- The Heubach acquisition brought in EUR 68 million in cash and cash equivalents
- RIECO subsidiary revenue declined 28% YoY to INR 228 crore with negative EBITDA due to project cost overruns
- Management guided for Heubach group EBITDA of EUR 35 million in FY2026, with a long-term target of EUR 90-100 million over the next 3 to 4 years
Beat or Miss?
| Metric | Reported | Analyst Estimate | Difference / Analysis |
| Full Year Revenue | INR 3,346 crore | Consensus est. ~INR 2,834 crore (implied) | Beat by ~18% |
| Full Year EPS (Diluted, Consolidated) | INR 7.86 | Consensus est. ~INR 17.1 | Missed by ~54% |
| Adjusted EBITDA (One Sudarshan, FY25) | INR 402 crore | N/A | N/A |
| Q4 FY2025 Legacy Sudarshan Revenue | INR 825 crore | N/A (prior year: INR 764 crore) | +8% YoY growth |
| Q4 FY2025 One Sudarshan Revenue | INR 1,349 crore | N/A | Includes 1 month Heubach |
| Net Profit Margin (FY2025) | 1.7-1.8% | ~14% (FY2024 baseline) | Sharply lower; acquisition dilution |
| Operating Cash Flow | INR 370 million | N/A | Down 80.9% YoY |
What Leadership Is Saying?
“Both these companies together, the new one Sudarshan, we feel that we could become the most value-creating pigment company with customer centricity and agility. As One Sudarshan, we have 19 manufacturing facilities in 11 countries across 5 continents. We represent all major industry segments. We have 4,000-plus global customers and a very large range of products. Our combined turnover is about 1 billion euros together and it’s a very exciting opportunity for us.” – Rajesh Rathi, Chairman and Managing Director, Sudarshan Chemical Industries Limited
“The sales for the quarter as far as legacy Sudarshan is concerned are at INR 825 crores, showing 8% growth over last year. Gross margin shows good improvement from 42.9% to 44.2%. EBITDA adjusted is at INR 402 crores for the full year compared to INR 316 crores. Net debt to equity is at 0.3. Net debt level at the year-end is at around INR 650 crores, and net working capital as a percentage of sales is at 25%.” – Nilkanth Natu, Chief Financial Officer, Sudarshan Chemical Industries Limited
Historical Performance
Sudarshan Chemical YoY Comparison (Standalone Pigments Business)
| Category | Q4 FY2025 | Q4 FY2024 | Change (%) |
| Revenue (Legacy Sudarshan) | INR 825 crore | INR 764 crore | 8.00% |
| Pigment Business Revenue | INR 744 crore | INR 644 crore | 15.50% |
| Adjusted EBITDA (Legacy) | INR 126 crore (15.2%) | INR 119 crore (15.6%) | 5.90% |
| Gross Margin (Legacy) | 44.2% | 42.9% | +130 bps |
Full Year Comparison
| Category | FY2025 (Consolidated) | FY2024 (Standalone) | Change (%) |
| Net Sales | INR 3,346 crore | INR 2,539 crore | 31.80% |
| Net Profit After Tax | INR 602 crore | INR 3,574 crore | -83.20% |
| Adjusted EBITDA | INR 402 crore | INR 316 crore | 27.20% |
| Gross Margin | 47.0% | 44.2% | +280 bps |
| Operating Cash Flow | INR 370 million | INR 1,935 million | -80.90% |
| EPS (Diluted, Consolidated) | INR 7.86 | INR 51.63 | -84.80% |
Competitor YoY Comparison
| Category | FY2025 | FY2024 | Change (%) |
| Sudarshan Chemical Revenue | INR 3,346 crore (~USD 386 million) | INR 2,539 crore (~USD 307 million) | +31.8% |
| DIC Corporation Net Sales | JPY 1,052.2 billion (~USD 7 billion) | JPY 1,071.1 billion (estimated) | -1.8% |
| Clariant AG Full Year Sales | CHF 3,915 million (~USD 4.4 billion) | CHF 4,152 million | -6.0% |
| Sudarshan Chemical Net Income | INR 602 crore | INR 3,574 crore | -83.2% |
| DIC Corporation Net Income | JPY 32.4 billion | JPY 21.4 billion (estimated) | +51.4% |
| Clariant AG Net Income | CHF -41 million (loss) | CHF 280 million | N/M |
| Sudarshan Adj. EBITDA Margin | ~12% (legacy Sudarshan) | ~12.4% | Stable |
| DIC Operating Income | JPY 52.2 billion | JPY 44.5 billion | +17.3% |
| Clariant EBITDA Margin (excl. excep.) | 17.8% | 15.9% | +190 bps |
How the Market Reacted?
The Q4 FY2025 earnings conference call was conducted on July 29, 2025, with results for the year ended March 31, 2025, announced on an audited basis after significant delays due to the complexity of consolidating Heubach Group’s 48 entities across three ERP systems. The stock has been under broad pressure, trading around INR 832 as of March 2026 against a 52-week high of INR 1,603 and a 52-week low of INR 777, reflecting a 13% decline year-on-year.
Analyst sentiment remains cautiously bullish, with Anand Rathi maintaining a Buy rating and a target price of INR 1,540, suggesting the market views the earnings decline as a transitional phenomenon tied to integration costs rather than fundamental deterioration. The stock’s post-results action reflected mixed sentiment: revenue growth and acquisition scale were seen as positives, while the deep fall in net profit, negative operating cash flow, and RIECO subsidiary underperformance tempered investor enthusiasm.
